药物开发的经济学:孤儿和非孤儿药物的比较
Virendra S Gomase1,2,3, Rupali Sharma2, Satish Sardana2
1Prin. L. N. Welingkar Institute of Management Development & Research (PGDM), Mumbai, 400019, India.
Current drug discovery technologies
|July 31, 2025
概括
孤儿药物开发的总体成本较低,但与非孤儿药物相比,每名患者的支出较高. 财政激励措施有助于罕见病药物研究,但可持续的资金对高患者成本至关重要.
科学领域:
- 药物经济学 药物经济学
- 药物开发经济学 药物开发经济学
背景情况:
- 由于市场规模,法规和激励措施,孤儿药和非孤儿药之间的药物开发成本有很大差异.
- 孤儿药物需要针对小患者群体和高患者成本的量身定制方法.
- 非孤儿药物面临着广泛的临床试验和市场竞争,因为目标人群较大.
研究的目的:
- 为了比较2010年至2020年间授权的孤儿和非孤儿药物的临床试验成本.
- 确定药物开发支出中的关键成本驱动因素和变化.
主要方法:
- 对孤儿和非孤儿药物的临床试验数据的比较分析 (2010-2020年).
- 关键指标包括试验持续时间,总开发成本和每个患者的成本.
- 来自行业报告和监管文件的二次数据被用于成本估计.
主要成果:
- 与非孤儿药物相比,孤儿药物具有较低的整体临床开发成本,但与非孤儿药物相比,每个患者的成本显著更高.
- 税收抵免和加速监管途径等财政激励措施降低了孤儿药物试验总体费用.
- 非孤儿药物由于更广泛的安全性/有效性评估和更大规模的III期试验而产生更高的成本.
结论:
- 孤儿药和非孤儿药具有不同的临床成本结构和经济权衡.
- 孤儿药物每患者的高成本强调了对可持续融资模式的需求.
- 数据支持利益相关者对药物开发的资源配置和投资做出明智的决策.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
848
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
848
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Bioequivalence: Overview
1.2K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.2K
Drug Administration and Therapy Phases: Overview
753
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
753


